Search Within

Heiko Schoder

  1. "Lymphoma"
Formats
  1. Journal Article (63)
  2. Meeting Abstract (61)
  3. Research Letter (4)
Groups
  1. Center for Hematologic Malignancies (128)
  2. Department of Medicine (128)
  3. Hematologic Malignancies, Division of (128)
  4. Lymphoma (128)
  5. Molecular Imaging and Therapy Service (128)
  6. Radiology, Department of (128)

More Groups

People
  1. Andrew Zelenetz (66)
  2. Alison Moskowitz (59)
  3. David Straus (56)
  4. Ariela Noy (55)
  5. Maria Palomba (53)
  6. Paul Hamlin (51)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (15)
  4. 2022 (7)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. Blood (49)
  2. Journal of Clinical Oncology (14)
  3. Hematological Oncology (10)
  4. Blood Advances (6)
  5. Leukemia and Lymphoma (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. American Society of Clinical Oncology (14)
  3. Wiley Blackwell (12)
  4. Nature Publishing Group (6)
  5. Taylor & Francis Group (5)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (128)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma
    Journal Article

    Mayerhoefer, M. E.; Riedl, C. C.; Kumar, A.; Gibbs, P.; Weber, M.; Tal, I.; Schilksy, J.; Schöder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information
    Meeting Abstract

    Nakajima, R.; Moskowitz, A. J.; Michaud, L.; Mauguen, A.; Schöder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • Five-year follow-up of SWOG S0816: Limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma
    Journal Article

    Stephens, D. M.; Li, H.; Schöder, H.; Straus, D. J.; Moskowitz, C. H.; LeBlanc, M.; Rimsza, L. M.; Bartlett, N. L.; Evens, A. M.; LaCasce, A. S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: Clinical outcomes of the phase III intergroup trial alliance/CALGB 50303
    Journal Article

    Bartlett, N. L.; Wilson, W. H.; Jung, S. H.; Hsi, E. D.; Maurer, M. J.; Pederson, L. D.; Polley, M. Y. C.; Pitcher, B. N.; Cheson, B. D.; Kahl, B. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma
    Journal Article

    Mehta-Shah, N.; Ito, K.; Bantilan, K.; Moskowitz, A. J.; Sauter, C.; Horwitz, S. M.; Schöder, H.
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Long-term follow-up of SWOG S0816: Response-adapted therapy for stage III/IV Hodgkin lymphoma demonstrates limitations of PET-adapted approach
    Meeting Abstract

    Stephens, D. M.; Li, H.; Schoder, H.; Straus, D. J.; Moskowitz, C. H.; Leblanc, M. L.; Rimsza, L. M.; Bartlett, N. L.; Evens, A. M.; LaCasce, A. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Initial results of a phase II study of sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance for untreated mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Zelenetz, A. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Laraque, L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • CALGB 50604: Risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET
    Journal Article

    Straus, D. J.; Jung, S. H.; Pitcher, B.; Kostakoglu, L.; Grecula, J. C.; Hsi, E. D.; Schöder, H.; Popplewell, L. L.; Chang, J. E.; Moskowitz, C. H.; more...
    Blood (2018)

    Fulltext@MSK | Save